Hhlr Advisors, LTD.

Hhlr Advisors, LTD. reported 35 holdings worth US$832M as of Jun 30, 2026 (Form 13F)

As of Jun 30, 2026 · Filed Aug 14, 2026

Hhlr Advisors, LTD. reported 35 holdings worth US$832M as of Jun 30, 2026. Largest: Arrivent Biopharma, Inc., Marvell Technology, Inc. and Ke Holdings, Inc. Class A. Filed Aug 14, 2026 (Form 13F).

Holdings
35
Value as reported
US$832M

The filing in full

CompanySharesValue as reported% of portfolio
Arrivent Biopharma, Inc.3.93MUS$136M16.4%
Marvell Technology, Inc.163KUS$48.5M5.8%
Ke Holdings, Inc. Class A2.22MUS$32.2M3.9%
Cytek Biosciences, Inc.6.66MUS$29.5M3.5%
Alamar Biosciences, Inc.956KUS$25.9M3.1%
Odyssey Therapeutics, Inc.832KUS$15.6M1.9%
Contineum Therapeutics, Inc.669KUS$11M1.3%
Maze Therapeutics, Inc.366KUS$10.9M1.3%
Taiwan Semiconductor Manufacturing Co., Ltd.15,510US$7.41M0.89%
Sagimet Biosciences Inc. - Series A725KUS$5.6M0.67%
Ge Aerospace10,043US$3.75M0.45%
Lumentum Holdings Inc.3,300US$2.83M0.34%
Nvidia Corporation14,054US$2.81M0.34%
Corning Incorporated10,266US$2.62M0.32%
Coherent Corp.6,417US$2.53M0.30%
Webull Corporation310KUS$2.02M0.24%
Intel Corporation14,300US$2M0.24%
Pacific Biosciences Of California, Inc.919KUS$1.54M0.19%
Texas Instruments Incorporated4,800US$1.43M0.17%
Gossamer Bio, Inc.4.97MUS$819K0.10%
Equinox Gold Corp.80,500US$782K0.09%
Zoom Communications, Inc.9,010US$778K0.09%
Aligos Therapeutics, Inc.76,247US$440K0.05%
Ridgetech, Inc.136US$204<0.01%

Source

View original at SEC

Related